Septerna Inc logo

Septerna Inc

SEPN
Healthcare|Biotechnology|USA
$35.93
-1.91 (-5.05%)
Tangible Book
$8.43

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 71.73, 66.9, 68, 61.7, 99.22 ], "ebit_estimate": [ -97.77, -142.66, -184.1, -251.93, -283.69 ], "ebitda_estimate": [ -58, -106, -149, null, null ], "net_income_estimate": [ -83.43, -130.87, -170.68, -202, -270.62 ], "per_share_eps_estimate": [ -1.76, -2.5, -2.87, -3.84, -4.15 ], "eps_nri_estimate": [ -1.76, -2.53, -2.89, -3.39, -4.12 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ 8.06, 11.74, 8.82, null, null ], "pretax_income_estimate": [ -83.29, -130.87, -170.68, -241.83, -270.62 ], "operating_cash_flow_per_share_estimate": [ -1.68, -2.31, -2.63, null, null ], "roa_estimate": [ -7, -14.6, -21.4, null, null ], "roe_estimate": [ -10.5, -18.3, -24.6, null, null ], "gross_margin_estimate": [ 100, 100, 100, 98, 94 ], "operating_cash_flow_estimate": [ -75.2, -103.39, -117.72, null, null ], "pettm_estimate": [ 0, 0, 0, 0, 0 ], "long_term_growth_rate_mean": -38.56, "long_term_revenue_growth_rate_mean": "11.70", "future_per_share_eps_estimate_growth": -38.09, "future_eps_nri_estimate_growth": -38.56, "future_revenue_estimate_growth": 11.7, "future_ebit_estimate_growth": -39.83, "future_ebitda_estimate_growth": -35.18, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -52.22, "future_pretax_income_estimate_growth": -52.26, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": -38.25, "future_roe_estimate_growth": -46.67, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 15.71, 15.71, 17.79, 9, 9, 9, 9 ], "ebit_estimate": [ -26.61, -28.85, -30.59, -55, -58, -60, -66 ], "ebitda_estimate": [ -12, -15, -18, null, null, null, null ], "net_income_estimate": [ -22.7, -25.07, -26.7, -50, -53, -56, -62 ], "per_share_eps_estimate": [ -0.47, -0.52, -0.53, -0.82, -0.81, -0.9, -0.92 ], "eps_nri_estimate": [ -0.46, -0.51, -0.53, -0.82, -0.81, -0.9, -0.92 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ -22.7, -25.07, -26.7, -50, -53, -56, -62 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 0, 0, 0, 0, null, null, null ], "long_term_growth_rate_mean": -38.56, "long_term_revenue_growth_rate_mean": "11.70", "future_per_share_eps_estimate_growth": -38.09, "future_eps_nri_estimate_growth": -38.56, "future_revenue_estimate_growth": 11.7, "future_ebit_estimate_growth": -39.83, "future_ebitda_estimate_growth": -35.18, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -52.22, "future_pretax_income_estimate_growth": -52.26, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": -38.25, "future_roe_estimate_growth": -46.67, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-07-01 13:38:41
2026-07-01 12:44:23
2026-07-01 12:38:07
2026-06-27 02:00:04